Oral Paclitaxel Efficacy Safety and PK in Recurrent and Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Recurrent or Metastatic Breast Cancer
Interventions: DRUG: DHP107|DRUG: IV Paclitaxel
Sponsor: Daehwa Pharmaceutical Co., Ltd.